RMD - ResMed president & COO Rob Douglas to retire amid several executive moves
2023-11-09 16:51:15 ET
More on ResMed
- ResMed: Down 60% With Tremendous Long-Term Potential
- ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
- ResMed Inc. (RMD) Q1 2024 Earnings Call Transcript
- ResMed stock declines after hours on FQ1 revenue miss, gross margin contraction
- ResMed Non-GAAP EPS of $1.64 beats by $0.02, revenue of $1.1B misses by $10M
For further details see:
ResMed president & COO Rob Douglas to retire amid several executive moves